Jorge E Romaguera (Jorge Romaguera)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2019
Publications (10 Years): 6

Top Venues

British journal of haematology

Cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Tamer Khashab, Fredrick Hagemeister, Jorge E Romaguera, Michelle A Fanale, Barbara Pro, Peter McLaughlin, M Alma Rodriguez, Sattva S Neelapu, Luis Fayad, Anas Younes, Lei Feng, Francisco Vega, Larry W Kwak, Felipe Samaniego
Long-term overall- and progression-free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non-Hodgkin lymphoma. British journal of haematology 185 (4) (2019)
Jorge E Romaguera, Michael L Wang, Lei Feng, Luis E Fayad, Frederick Hagemeister, Peter McLaughlin, M Alma Rodriguez, Michelle Fanale, Robert Orlowski, Larry W Kwak, Sattva Neelapu, Yasuhiro Oki, Barbara Pro, Anas Younes, Felipe Samaniego, Nathan Fowler, Kimberly Hartig, Marisa Valentinetti, Judy Smith, Peggy Ford, Adam Naig, L Jeffrey Medeiros, Hagop M Kantarjian, Andre Goy
Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma. Cancer 124 (12) (2018)
Jorge E Romaguera, Jee Hun Lee, Rohinton Tarapore, Varun Prabhu, Joshua Allen, Lee Schalop, Andrew Zloza, Chi Y Ok, Evita T Sadimin, Jason Schenkel, Maria Badillo, Michael Wang
Integrated stress response and immune cell infiltration in an ibrutinib-refractory mantle cell lymphoma patient following ONC201 treatment. British journal of haematology 185 (1) (2018)
Preetesh Jain, Jorge E Romaguera, Samer A Srour, Hun J Lee, Frederick Hagemeister, Jason Westin, Luis Fayad, Felipe Samaniego, Maria Badillo, Liang Zhang, Lorreta Nastoupil, Rashmi Kanagal-Shamana, Nathan Fowler, Michael L Wang
Four-year follow-up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL). British journal of haematology 182 (3) (2018)
Preetesh Jain, Rashmi Kanagal-Shamanna, Shaojun Zhang, Makhdum Ahmed, Ahmad Ghorab, Liang Zhang, Chi Young Ok, Shaoying Li, Frederick Hagemeister, Dongfeng Zeng, Tiejun Gong, Wendy Chen, Maria Badillo, Krystle Nomie, Luis Fayad, Leonard J Medeiros, Sattva Neelapu, Nathan Fowler, Jorge E Romaguera, Richard Champlin, Linghua Wang, Michael L Wang
Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib. British journal of haematology 183 (4) (2018)
Jee Hun Lee, Maria Badillo, Jorge E Romaguera, Michael Wang
A phase II study of carfilzomib in the treatment of relapsed/refractory mantle cell lymphoma. British journal of haematology 184 (3) (2018)

Jorge E Romaguera.css-eqlu8i{font-size:small;padding-left:4px;} (Jorge Romaguera)

Publication Activity (10 Years)

Top Topics

Top Venues

Jorge E Romaguera (Jorge Romaguera)